Page last updated: 2024-09-04

tuftsin and Leukopenia

tuftsin has been researched along with Leukopenia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Firoz, A; Jabeen, R; Khan, MA; Mohammad, O1
Khan, MA; Nasti, TH; Owais, M1
Khan, A; Khan, MA; Owais, M1
Coleman, DL1

Reviews

1 review(s) available for tuftsin and Leukopenia

ArticleYear
Regulation of macrophage phagocytosis.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:1

    Topics: Anemia, Sickle Cell; Biological Products; Blood Flow Velocity; Complement C3; Cytokines; Heart Failure; Hemorrhage; Humans; Hypertension, Portal; Immunoglobulin G; Interferon-gamma; Leukopenia; Liver Cirrhosis; Macrophages; Mononuclear Phagocyte System; Opsonin Proteins; Phagocytes; Phagocytosis; Purpura, Thrombocytopenic; Receptors, Fc; Splenectomy; Tuftsin; Wounds and Injuries

1986

Other Studies

3 other study(ies) available for tuftsin and Leukopenia

ArticleYear
Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice.
    Journal of drug targeting, 2004, Volume: 12, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Compounding; Drug Resistance, Fungal; Female; Immunologic Factors; Intercalating Agents; Kidney; Leukopenia; Lipopolysaccharides; Liposomes; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nystatin; Staphylococcal Protein A; Tuftsin

2004
Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Dose-Response Relationship, Drug; Drug Synergism; Immunologic Factors; Leukocytes; Leukopenia; Liposomes; Lung; Mice; Mice, Inbred BALB C; Tuftsin

2005
Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    FEMS immunology and medical microbiology, 2006, Volume: 46, Issue:1

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Immunologic Factors; Kidney; Leukopenia; Liposomes; Macrophages; Mice; Mice, Inbred BALB C; Phagocytosis; Tuftsin

2006